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Objectives: Exacerbations of chronic obstructive pulmonary disease (COPD) are the third 
largest cause of emergency hospital admissions in the UK. This systematic literature review 
explored the relationship between the hospitalization rates and the COPD comorbidities, anxiety, 
and depression.
Methods: The Centre for Research Dissemination’s framework for systematic reviews was 
followed using search terms relating to COPD, anxiety, depression, and hospital admission. 
Papers identified were assessed for relevance and quality, using a suitable Critical Appraisal 
Skills Programme tool and Mixed Methods Assessment Tool.
Results: Twenty quantitative studies indicated that anxiety and depression led to a statistically 
significant increase in the likelihood of COPD patients being hospitalized. These comorbidi-
ties also led to an increased length of stay and a greater risk of mortality postdischarge. Other 
significant factors included lower Body-Mass Index, Airflow Obstruction, Dyspnea, and 
Exercise scores, female gender, lower socioeconomic status, poorer patient perceived quality 
of life, increased severity of lung function, and less improvement in dyspnea from admission 
to discharge. It was also highlighted that only 27%–33% of those with depression were being 
treated for it. Four qualitative studies revealed that patients saw anxiety and depression as a 
major factor that affected their ability to cope with and self-manage their condition.
Implications: Findings from the systematic review have highlighted a need for better recogni-
tion and treatment of anxiety and depression amongst individuals with COPD. Ongoing research 
will develop and test strategies for promoting better management and self-management as a 
means of reducing hospital admissions.
Keywords: COPD, exacerbations, depression, anxiety, hospital admissions
Background
Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity 
and mortality worldwide. The 2002 World Health Report1 listed COPD as the fifth 
leading cause of death in the world. Further increases in its prevalence and mortality 
are expected to make it the third leading cause of mortality by 2015.2,3 COPD is a 
complex disease, triggered mostly by exposure to cigarette smoking. It leads not only 
to pulmonary damage but also to systemic impairment. There is also a growing aware-
ness of systemic inflammation, cardiovascular, neurologic, psychiatric, and endocrine 
morbidities that are common comorbidities of the condition and have a long-term 
detrimental effect on the morbidity and mortality of COPD patients.4,5
COPD has a major effect on the lives of the sufferers, particularly in terms 
of impaired exercise performance and functional capacity. The presence of daily 
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 symptoms and a high exacerbation frequency are other 
important  factors.6 COPD also accounts for many visits to 
health care professionals in the UK. General practitioner 
consultations for COPD in one year range from 4.17 per 
1,000 consultations in people aged 45–64 years to 8.86 per 
1,000 in 65–74 years to 10.32 per 1,000 in 75–84 year 
olds.7–9 These rates are four times those for the chest pain 
caused by ischemic heart disease. Exacerbations are also an 
important cause of hospitalization and are responsible for 
about 10% of all acute medical admissions.10,11 They are also 
the second largest cause of unplanned hospital admissions12 
and strongly influence the health-related quality of life for 
the sufferer.5,13–15
Donaldson et al16 demonstrated that the frequency of 
the occurrence of the acute exacerbations contributed to 
long-term decline in lung function in COPD. They showed 
that patients with COPD who suffered frequent exacerba-
tions experienced a significantly greater decline in forced 
 expiratory volume in 1 second (FEV
1
) than patients who had 
infrequent exacerbations. Exacerbations are more common 
than previously believed (2.5–3 per year [mean]).13 Also, 
following an exacerbation, the incomplete recovery of lung 
function after the event means that the patient may not regain 
his or her stable lung function, which may contribute to a 
decline in lung function with time, which is characteristic 
of COPD.14–16 These findings emphasize the importance of 
targeting COPD exacerbations to reduce disease progres-
sion and, particularly, to detect patients who are frequent 
exacerbators and the underlying factors that contribute to 
these exacerbations.
Anxiety and depression are common comorbidities of 
COPD.17–19 The literature also suggests that there may be a 
relationship between these comorbidities and the exacerba-
tions of COPD.20 This literature is not, however, conclusive21,22 
due to: different tools being used to measure anxiety and 
depression; studies being conducted in different countries that 
have noncomparable health services; and some studies that 
include asthmatics, as well as people with COPD. Untreated 
or incompletely treated depression and anxiety may also have 
major implications for compliance with medical treatment, 
due to the effects on cognitive functioning and the decreased 
effectiveness of any self-management activities that the person 
may instigate.23–25 The way in which anxiety and depression 
may be associated with COPD exacerbations may also have 
a relationship with this issue of ineffective  coping and self-
management strategies adopted by the patients.  Depression 
may also be a significant predictor of mortality following 
hospitalization for acute exacerbation.26
Aim and objectives
In this paper, we wanted to examine critically the relation-
ship between anxiety/depression and the exacerbations 
of COPD that result in hospital admission and readmis-
sions and to investigate whether there are other mediating 
 factors involved.
Objectives
Our objectives were: 1) to clarify the evidence base available 
regarding the relationship between anxiety/depression and 
the exacerbations of COPD that lead to hospital admissions 
and readmissions; and 2) to identify any other factors that 
might lead to the hospitalization following an exacerbation 
of COPD patients with the comorbidities of anxiety and 
depression. These other factors may also include the ability 
to cope and to self-manage their condition, as well as other 
comorbidities and social factors. 
Materials and methods 
A systematic review of the literature was carried out following 
the University of York’s Centre for Reviews and Dissemina-
tion’s (CRD) guidance.27 The review question was framed in 
terms of population, investigation, outcome, and study design 
(PIOS), with the population being anyone with COPD – any 
age, any gender, and any severity. The conclusion of the 
investigation was that these people had the comorbidities of 
anxiety and/or depression, and the outcome was admission 
to the hospital for the exacerbation of COPD.
The study design for the research studies sourced was 
not specified and not restricted by date or place where the 
study was carried out; this was done so as not to restrict the 
review. The inclusion criteria for the review were studies 
relating to having COPD and the comorbidities of anxiety 
and depression and patients being admitted to the hospital 
with an acute exacerbation of COPD.
Initially, the Cochrane Review database was searched 
to ensure that a similar review had not already been carried 
out nor was it in the process of being conducted. Electronic 
databases were then searched to elicit literature relevant to 
the review question set. These electronic databases included 
PubMed/Medline, Cumulative Index to Nursing and Allied 
Health Literature, Embase, Web of Science, and PsycINFO. 
The search terms were broken down in terms of PIOS and 
outlined in Table 1.
Following the searches of these individual areas that used 
OR to combine all the terms, the population search terms 
were then combined with the outcome search terms with OR; 
they were then further combined with the intervention search 
International Journal of COPD 2014:9
Table 1 Search terms used in the electronic database search
PIOs component Search terms used (including MeSH,  
thesaurus, truncated terms)
How search terms were combined
Population (having COPD) COPD; COAD; chronic obstructive  
pulmonary disease; chronic obstructive  
airways disease; bronchial disorders;  
pulmonary emphysema; pulmonary disease
#1 combined terms for Population with OR
Investigation (having  
comorbidities of anxiety  
and/or depression)
anxi*; anxiety; anxiety disorders; acute  
anxiety; depress*; depressive disorder;  
depression; depressive episode
Combines search #6 with search terms for anxiety with AND 
(#7) (this gave final articles for anxiety); combined search #6  
with search terms for depression with AND (#8) (this gave  
final articles for depression)
Outcomes (having an  
exacerbation of COPD and  
being admitted to hospital)
exacerbat*; disease exacerbation; disease  
progression; admission; hospital admission;  
hospitalization; hospital discharge
#2 combined search #1 with terms for exacerbation with OR 
(#3); #4 combined search #1 with terms for hospital admissions 
with OR (#5); then, combined search #3 with #5 with OR 
(COPD, exacerbations and hospital admission searches) (#6)
Abbreviations: PIOs, population, investigation, outcome, and study design; MeSH, medical subject headings; COPD, chronic obstructive pulmonary disease; COAD, chronic 
obstructive airways disease.
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terms, using the search words “anxiety” and “depression” 
separately – combining with AND for the final outcome of 
the searching.
Other potential research papers were identified from 
the reference lists of the articles read in full text for the 
final review. Abstracts from relevant conferences that were 
identified by the database searches were also reviewed, and 
authors were contacted for further information on relevant 
abstracts. This extra clarification and checking process has 
been identified by the CRD27 as good practice to ensure a 
complete inclusion of relevant data.
The selection of the studies retrieved from the electronic 
searching was done in distinct stages. Initially, all duplica-
tions were removed. Then, the titles and abstracts were 
reviewed against the inclusion criteria for the review. Remain-
ing articles were then screened by reading the full text, which 
then left the remaining articles to be reviewed in a final review 
(Figure 1). Two researchers reviewed the full-text articles to 
decide on the final articles to be included. A third reviewer 
was available to resolve any disagreements that occurred in 
this process. This peer review was also carried out during the 
data extraction stage of the review.
The systematic review of the literature was carried out 
May 2012–September 2012. It should be stressed however 
that although the last search was run at the end of September 
2012, an alert system was set up on the electronic search 
databases to highlight any new research being published 
that may have had relevance to the search area topic. When 
this paper was submitted for publication, no further research 
publications had been identified that addressed the question 
set in this systematic review.
Data extraction was carried out using the Strengthening 
the Reporting of Observational Studies in Epidemiol-
ogy (STROBE) guidelines28 for the individual study 
designs that were included in the final review. The meth-
odology of the articles was reviewed using the appropriate 
Critical Appraisal Skills Programme tool for critique of 
literature.29
During the data-extraction stage of the review,  quality 
checks were carried out on each individual study to be 
included in the final systematic review. For this process, 
the Mixed Methods Appraisal Tool version 2011 (MMAT, 
Department of Family Medicine, McGill University, 
 Montreal, QC, Canada) was used.30
The MMAT has been designed for the appraisal stage 
of complex systematic literature reviews that include 
qualitative, quantitative, and mixed methods studies. The 
MMAT permits the reviewer to appraise concomitantly 
and describe the methodological quality for the three 
methodology domains: mixed, qualitative, and quantita-
tive;  subdivided into three sub domains; and randomized 
controlled trials, nonrandomized, and descriptive. The 
MMAT allows the appraisal of most common types of 
study methodology and design; different sections of the 
tools are used for the appraisal of the different study types. 
For each relevant study selected for a systematic mixed 
studies review, the methodological quality can then be 
described using the corresponding criteria. The MMAT 
has been designed to appraise the methodological qual-
ity of the studies retained for a systematic mixed studies 
review, not the quality of their reporting (writing). This 
distinction is important – as good research may not be 
well-reported.
The scoring metrics for the MMAT can be presented as 
*, **, ***, or ****, where the * represents the number of cri-
teria met, divided by 4. This becomes: the single *  represents 
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25%; the **, 50%; the ***, 75%; and the ****, 100%, and 
represents top quality.
Due to the heterogeneity of the final articles included 
in the review, the methodology chosen for the synthesis of 
the findings was via narrative synthesis, using the guidance 
developed by Popay et al31 to provide some structure and 
transparency of the results generated.
Method of synthesis
“Narrative synthesis” refers to an approach to the systematic 
review – the synthesis of findings from multiple studies that 
relies primarily on the use of words and text to summarize 
and explain the findings of the synthesis.31
The narrative synthesis guidance31 identif ies four 
 elements of the process of narrative synthesis: 1) developing 
a theory of how the intervention works, why, and for whom; 
2) developing a preliminary synthesis; 3) exploring the rela-
tionships within and between the studies; and 4)  assessing 
the robustness of the synthesis.
For each element of the synthesis process, the guidance 
describes a number of useful tools and techniques. The 
choice of specific tools and techniques at each point in the 
process will depend on the type of data being synthesized. 
Only the tools and techniques actually used in this synthesis 
are described in this article. Figure 2 illustrates the synthesis 
process.
Articles identified from initial
searches of electronic databases;
n=494 
Articles identified from reading
abstracts; n=159 
Articles for full-text reading and
assessment of eligibility; n=125  
Articles meeting the inclusion
criteria for the review; n=28  
Articles to be included in the final
review; n=24 
(Articles to be synthesized to answer
research question set for systematic
review) 
Articles identified from reference lists;
n=12; ×2 taken into final review 
Articles identified from hand searching
journals; n=0; (all duplicates of what
already got)
Duplicate publications
removed; n=34  
Articles excluded following analysis and
critique of full text (give reasons); n=6  
×1 looked only at mortality after
discharge, ×1 looked at symptoms and
relationship with depression and
anxiety, ×1 looked at primary care
exacerbations in mild COPD, ×1 best
assessment tool for COPD as a whole
with anxiety and depression, ×2 literature
reviews had already been included in 
the review  
Figure 1 Flow chart of study selection process.
Abbreviation: COPD, chronic obstructive pulmonary disease.
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Results
Theoretical development
COPD exacerbations are best defined as the worsening of 
respiratory symptoms.14 More strategies to reduce exacerba-
tion frequency urgently need to be delivered and evaluated. 
Clinicians will be in a better position to reduce the morbidity 
associated with COPD exacerbations significantly and – at 
last – improve the quality of life for our patients with this 
debilitating condition. Hence, it is important to understand 
the relationship between the comorbid conditions of anxiety 
and depression and the acute COPD exacerbations that result 
in hospital admissions. Theories can then be developed to 
postulate on such a relationship and other mediating factors 
involved, but the facts cannot be unveiled without undertak-
ing this systematic review and conducting a thorough and 
systematic synthesis of the findings. Only then will the nature 
of this relationship and, indeed, if other factors are involved, 
be discovered.
Figure 3 illustrates the theoretical relationship between 
anxiety and depression and the acute exacerbations of COPD 
that result in admission or readmission to the hospital.
Preliminary synthesis
The guidance suggests that the way in which a reviewer 
approaches the preliminary synthesis will depend – in part – 
on whether the evidence to be synthesized is  qualitative, 
quantitative, or both.31 In this synthesis, the data to be 
 synthesized is predominantly quantitative from the method-
ologies of cohort and case control/series nature, amounting 
to 20 studies.
There were also three qualitative studies and one mixed-
method study. With this in mind, the tools utilized in this 
preliminary synthesis are textual description, tabulation of 
data, groupings, and clusters.
The purpose of this preliminary synthesis is to deliver 
an initial description of the results of the individual studies 
24 papers addressing the relationship
between anxiety, depression, acute
exacerbation of COPD, and hospital
admission 
Develop a preliminary synthesis 
Relevant tools, techniques 
• Textual descriptions 
• Tabulation 
• Groupings and 
clustering 
• Content analysis Exploring relationships within and
between studies 
Assessing robustness 
Conclusions and recommendations 
Relevant tools, techniques 
• Variability in outcomes 
• Study design and study 
population 
• Examination of moderator 
variables and subgroup 
analysis 
• Idea webbing and 
conceptual mapping 
• Textual descriptions 
Relevant tools, techniques 
• Weight of evidence 
• Best evidence synthesis 
• Critical reflection
Figure 2 Synthesis process used in the review of the literature.
Abbreviation: COPD, chronic obstructive pulmonary disease.
Increased
anxiety and
depression  
Increased
exacerbations  
Increased
hospital
admissions  
Decreased
ability to cope  
Figure 3 Diagrammatic representation of the theoretical relationship between 
anxiety and depression and acute exacerbations of COPD that result in hospital 
admissions or readmission.
Abbreviation: COPD, chronic obstructive pulmonary disease.
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included in the systematic review, which relate to the pri-
mary research question asked at the start of the systematic 
review. Through this, the reviewer will begin to construct 
an explanation of how and why a particular factor had the 
relationships reported, of how and why particular factors 
impinged in situations, and to test the robustness of the 
results of the synthesis.
Tabulation of data was considered the most natural start-
ing point for the synthesis while extracting data from the 
included studies during the review process. This is shown in 
Table 2, which provides a summary of all the studies included 
in the systematic review.
It is apparent from Table 2 that the majority of the stud-
ies directly supported the notion that there was a positive 
relationship between anxiety and depression and the resul-
tant admissions or readmissions to the hospital for an acute 
exacerbation of COPD. Findings also highlighted other 
mediating factors that were involved in this relationship. 
These included: perceived quality of life; severity of disease; 
female sex; lower body-mass index, airflow obstruction, 
dyspnea, and exercise (BODE) scores (an index of COPD 
mortality; the lower the score, the more chance of death 
from COPD); low socioeconomic status; persistent smoking; 
long-term oxygen therapy (LTOT); decreased self-efficacy 
and compliance; increased dyspnea; a sense of loss; and an 
inability to cope and previous admissions for acute exacer-
bation of COPD.
Another important factor demonstrated by the results 
in Table 2 was the heterogeneity of the studies, in terms of 
populations, country of origin, sample sizes, statistical tests 
applied, and outcomes. The data extraction table (Table 2) 
was examined in more depth to determine the presence of 
dominant groups or clusters of characteristics, by which 
the subsequent synthesis could be organized. These group-
ings incorporated study methodology, populations under 
study and settings, factors under investigation, and out-
comes recorded. Table 2 was organized into the different 
 methodologies. From this, it was apparent that in studies of 
the same basic methodology, different factors were included 
in the models under investigation. Some used the measure-
ment of depression and anxiety; some used one of these 
conditions alone. There was also variation in the tools used 
to measure these factors.
In addition, some studies used depression and anxi-
ety as secondary outcome measures, with the quality of 
life and BODE scores as the primary outcome measures 
under investigation. The end results, though, still yielded 
 information that could contribute to the answering of 
the research question set at the start of the systematic 
review.
From comparing and cross reading the included stud-
ies in the final systematic review, there is evidence that the 
comorbidities of depression and anxiety do have a significant 
relationship with higher rates of admissions and readmissions 
for the acute exacerbation of COPD.26,32–44 This was found in 
17 of the final 24 (71%) studies.
Other areas shown from the included studies were that 
the presence of the comorbidities of depression and  anxiety 
meant that once admitted, patients had longer lengths 
of stay in the hospital48 and a greater risk of mortality 
postdischarge.20,26,32,41
Mediating factors observed to be significant in this rela-
tionship between the comorbidities of anxiety, depression, 
and the acute exacerbation of COPD included: lower BODE 
scores;19,32,33 perceived quality of life, which also had a direct 
correlation with worsening depression and increased risk 
of exacerbations;19 lower socioeconomic status;37 increased 
severity of anxiety; female sex;19,34,44,45 increasing rate of 
decline in lung function;36 less improvement in dyspnea; 
increased partial pressure of carbon dioxide (PaCO
2
); 
decreased partial pressure of oxygen (PaO
2
); and increased 
pH from admissions to discharge.34,43,46
It was also highlighted that only 27%–33% of patients 
with depression and COPD were being treated with anti-
depressant medication, which suggests the underdiagnosis 
and undertreatment of depression in the COPD population.41 
This proposition – that depression is underdiagnosed41 – is 
also supported by the findings of Fan et al,47 who stated that 
although there is a high prevalence of depression in COPD 
patients, only 33% receive any medication for it. There 
was no data relating to nonpharmacological-management 
techniques.
Analysis for the qualitative studies, which examined 
patients’ perceptions and subjective experiences, suggested 
that anxiety should be seen as an important issue for COPD 
patients. Anxiety might provide an important indicator of 
actual illness severity and assist clinicians in determining the 
support and care that these people require.48 It is essential, 
then, that anxiety is recognized as an important sign but not 
necessarily the cause of dyspnea for patients with COPD in 
acute exacerbation. It was also highlighted that depression 
is significantly related to decreased quality of life, which – 
in turn – can lead to decreased compliance, resulting in an 
increased incidence of exacerbations and the associated risk 
of mortality on discharge following the exacerbations.41 The 
relationship between depression and lower levels of quality of 
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life was also highlighted by Coventry et al,37 Gudmundsson 
et al,19 Ng et al,45 and Xu et al.44
An examination of the patients’ perceptions and experi-
ences in the qualitative and mixed methods studies showed 
that they felt a real sense of loss of control over their health, 
which led to an increased dependence and loss of autonomy.52 
These consequences imposed on the patients also triggered an 
increase in depression and a resultant decrease in the quality 
of life.39 Their ability to cope was compromised, which again, 
led to increased levels of anxiety and depression.39 These 
perceptions and experiences were also confounded by the 
perceived lack of information and guidance given to patients 
postdischarge, which led to increased levels of anxiety.39
It can be seen from this synthesis of the data that the 
 relationship of anxiety and depression to the acute exac-
erbation of COPD is significant, but it is also complex, 
 multifaceted, and concerns many interrelated factors. These 
factors build on the preliminary theoretical model shown 
in Figure 2; the expanded theoretical perspective of this 
 relationship is shown in Figure 4.
It is important to point out that there were two studies 
which reported that anxiety and depression were not signifi-
cant factors in the relationship between the exacerbations 
and the hospital admissions. These two studies were by Soler 
et al50 and Chen and Narsavage.51 On closer examination of 
these two studies, the study by Chen and Narsavage51 was 
carried out in rural Taiwan. It was acknowledged within 
the paper itself that rural and cultural subgroups may have 
different perceptions of their condition, especially of hav-
ing depression, which is regarded quite negatively by some 
cultures. This may have affected the perceptions and feedback 
from the participants about their condition when interviewed 
and even how they presented to the hospital, as some cultures 
would suffer at home rather than go to the hospital. It was also 
noted that the participants would access different hospitals 
in a wide area, which could make the collection of quality 
data difficult to achieve.
The study by Soler et al50 only examined anxiety and – 
although it showed itself to be a significant factor in the 
relationship under question – depression was excluded. Very 
often, however, these two conditions were present together 
in the person. They highlighted that significant factors were 
the use of inhaled salmeterol (a long-acting bronchodilator 
inhaler medication) and, also, cardiac arrhythmias.
On a closer examination of the study group character-
istics, the majority of participants were on salmeterol at 
the start of the study, which was not the case in the other 
studies included in the review. Also, the study group only 
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consisted of people with severe COPD, in which cardiac 
arrhythmias are commonly found as a comorbidity. It is not 
surprising, therefore, that both of these factors had a higher 
chance of showing themselves to be significant. Although 
these findings are relevant if relating the findings to only 
people with severe COPD, this review is considering the 
relation of anxiety and depression to acute exacerbations 
and resultant hospital admissions and readmissions to the 
general COPD population, which the other studies in the 
review consider. 
This model (Figure 4) builds on the original theory of 
the relationship between anxiety and depression and the 
exacerbations of COPD. The additional variables are those 
discovered from the systematic review of the literature, and 
they enhance the preliminary theoretical model further in 
the quest to gain a deeper understanding of the relationship 
under review.
Finally, during the process of data extraction, quality 
checks on the methodology of all the included articles in 
the review were carried out using the MMAT version 2011.30 
Quality appraisal of all the included studies in this systematic 
review showed that 16 of 24 (66% or two-thirds) had a **** 
rating. Therefore, they met 100% of the quality criteria, and 
eight (33% or one-third) had a quality rating of ***. There-
fore, they met 75% of the quality criteria used, a number that 
was still symbolic of high-quality studies. The reasons for the 
drop in the star rating to three stars were: because there was 
no information about the missing data or the dropout rate of 
the participants (n=6); invalid tools were used to measure the 
outcomes (n=1); and there was no consideration of how the 
researcher involved in the study influenced the participants 
(n=1). Overall, the quality of the included studies in this 
systematic review was of high, if not good, quality – meet-
ing between 75%–100% of the quality criteria in the MMAT 
evaluation tool.
Reflecting critically on the process  
of narrative synthesis
The synthesis of mixed study results does not have the rigor-
ous techniques and tools that are available to meta analysis. 
This is not to say that the quality of the content and results 
of the systematic review are any less valuable. The question 
that was originally identified lent itself to both qualitative and 
quantitative study results; this is why the inclusion criteria 
were kept wide.
The problem with the narrative synthesis up until 
now has been that there was no standard way in which 
the literature was synthesized. It was left to the personal 
preference and also to the experience of the reviewers; 
therefore, transparency and rigor could be arguably flawed. 
The guidance on the narrative synthesis31 helps to enhance 
the quality and transparency of narrative synthesis and, 
hence, why it was chosen for the synthesis stage of the 
overall systematic review. The amount of methodological 
Increased
anxiety and
depression
Increased
exacerbations 
Increased
hospital
admissions
Decreased
ability to cope 
Decreased
quality of
life
Increased
dyspnea
Increased
mortality
postdischarge
Increased
length of stay in
hospital
Decreased
self-esteem 
Increased
loss of
autonomy
Figure 4 Idea webbing of factors involved in the relationship of anxiety and depression and the acute exacerbation of COPD.
Abbreviation: COPD, chronic obstructive pulmonary disease.
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heterogeneity in the studies included in the final system-
atic review also led to the decision to undertake such a 
method of synthesis.
The levels of bias were reduced by having a second 
reviewer (an experienced qualitative researcher) at the selec-
tion and data extraction stages of the systematic review; 
this reviewer also reviewed the narrative synthesis once 
completed. It was also reviewed by an expert in the field of 
narrative synthesis and one of the main authors of the nar-
rative synthesis guidance. This peer review process aimed to 
reduce any possible bias that may have resulted if the whole 
process had been undertaken single-handed.
Discussion
For decades, the psychiatric morbidity of medically ill 
patients has been acknowledged. However, there has been 
relatively little focus on psychiatric disorders in patients 
with COPD, except for prevalence studies.41,52 The results 
of this systematic review have highlighted a relationship 
between anxiety and depression and the admission to the 
hospital with acute exacerbations of COPD. It has also been 
observed that more evidence is needed to substantiate the 
evidence further.
COPD is a severe and irreversible pulmonary disease that 
impacts the patient’s general physical condition, functioning, 
and quality of life.53 COPD patients constitute a substantial 
part of the medically ill patients, both in hospital wards and 
in outpatient clinics. They present a considerable challenge 
to the health care system.3,46,54
The association between COPD and psychiatric 
 disorders – in particular generalized anxiety, panic disor-
der, and depression – has been acknowledged for many 
years. The prevalence of psychiatric comorbidity in these 
patients, as well as the effect of treatment and the prognosis, 
remains unclear. The diagnostic procedure is complicated by 
an overlap or close association of somatic and psychiatric 
symptoms in COPD patients who suffer from comorbid 
anxiety and depression.
Caring for such an irreversible condition is challeng-
ing, with the most important task being not to cure but to 
optimize the quality of life of the individual patients.54 The 
quality of life of a chronically ill patient may be particularly 
complicated by a concurrent depressive disorder that may 
bring the patient into a vicious circle. The depressed mood 
will lower the ability needed to cope with the chronic disease. 
The physical symptoms will then become less tolerable, and 
the psychosocially debilitating effect of the disease may be 
enforced by the depressed mood.55,56
The impact of anxiety and depression on COPD patients, 
their families, and society is significant. Depressed patients 
with a chronic medical illness are usually sicker than their 
counterparts55,57 and have lower treatment adherence.56,58,59 
Depression adversely affects physical functioning in people 
with COPD, such as a reduced 12-minute walk distance.56 
By compromising health status, mood disorders may lead to 
an increased risk of hospitalization20 and rehospitalization.19 
Depression may also be a significant predictor of mortality 
following hospitalization for acute exacerbation.26
Exacerbations of COPD cause morbidity, hospital admis-
sions, and mortality; they strongly influence health-related 
quality of life.13 Physiological recovery after an exacerba-
tion is often incomplete, which decreases the health-related 
quality of life and resistance to future exacerbations. It is 
important to identify COPD patients who suffer from frequent 
exacerbations.
More strategies to reduce exacerbation frequency urgently 
need to be delivered and evaluated. We will then, as clinicians, 
be in a better position to reduce the morbidity associated 
with COPD exacerbations significantly and, at last, improve 
the quality of life of patients with this debilitating condition. 
Therefore, there is a need to understand the relationship of the 
comorbid conditions of anxiety and depression to COPD and 
the acute exacerbation that results in hospital admissions, and 
a need to determine if there are any other factors involved. 
This systematic review has highlighted that there is a rela-
tionship between anxiety and depression and an increased 
number of exacerbations, resulting in hospital admission 
for people with COPD. This relationship, however, is not a 
simple linear one; many other mediating factors have also 
been discovered. It has also highlighted the heterogeneity 
of the evidence base that is currently available and the need 
for a more consistent approach in future research strategies 
to address this area of clinical importance so that clinical 
decision making can be made with accuracy.
Conclusion
Following the synthesis of the data from the systematic 
review to answer the question “what is the relationship of 
anxiety and depression to the exacerbations of COPD and 
the resultant admissions/readmissions to hospital, and are 
there any other mediating factors involved,” the concluding 
remarks are:
1. Some literature supported the fact that anxiety and 
depression were significant factors in patients’  admissions 
and readmissions to the hospital following an acute 
 exacerbation of COPD.
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2. The literature also highlighted other significant factors 
in the relationship between anxiety, depression, and 
the acute exacerbation of COPD resulting in admission 
and readmission to hospital. These factors included: 
reduced quality of life; increasing severity of disease; 
female  gender; lower BODE scores; low socioeconomic 
status; persistent smoking; increased dyspnea; PaCO
2
 
and decreased PaO
2
 from admission to discharge; LTOT; 
sense of loss and inability to cope; decrease in self-
efficacy and compliance with treatment; and previous 
admissions for acute exacerbation of COPD.
Although this goes some way to answering the research 
question set at the start of the systematic review, for any 
significant changes to be implemented into clinical practice, 
further research needs to be carried out. The examination 
of literature review indicated several implications for the 
conduct of research in this area; and further research should 
consider using standardized tools to measure the outcomes, 
using more comparative study participants and not just men, 
or groups of COPD patients who were already involved 
in another study about their disease state. Some studies 
in this systematic review were done in different countries 
with different cultural groups who have differing beliefs 
about diseases. This was discussed by these study authors 
as being a significant confounding factor; future research 
should consider and accommodate for this in study design 
and methodology.
This systematic review was a preliminary review of the 
literature into this important area of clinical care. Managing 
depression and anxiety starts with an accurate diagnosis. 
Many COPD patients have transitory mood symptoms during 
exacerbations that improve spontaneously as their physical 
state improves. The challenge is: to identify those who have 
more permanent and sustained anxiety and depression; to 
develop ways of screening for and then implementing effec-
tive management strategies to alleviate the impact of these 
comorbidities; and to enable them to cope better with their 
COPD. The end result should be a reduction in the number 
of exacerbations that result in unplanned admissions to 
hospital, which have a devastating effect on the patients and 
their families.
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